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At the site of injury activated platelets release various mediators, one of which is
sphingosine 1-phosphate (S1P). It was the aim of this study to explore whether activated
human platelets had a pronociceptive effect in an in vivo mouse model and whether
this effect was based on the release of S1P and subsequent activation of neuronal S1P
receptors 1 or 3. Human platelets were prepared in different concentrations (105/µl,
6 7 fl fl10 /µl, 10 /µl) and assessed in mice with different genetic backgrounds (WT, S1P
/
,1
SNS-S1P
−/−
, S1P
−/−
). Intracutaneous injections of activated human platelets induced1 3
a significant, dose-dependent hypersensitivity to noxious thermal stimulation. The degree
of heat hypersensitivity correlated with the platelet concentration as well as the platelet
S1P content and the amount of S1P released upon platelet activation as measured
with LC MS/MS. Despite the significant correlations between S1P and platelet count,
no difference in paw withdrawal latency (PWL) was observed in mice with a global
null mutation of the S1P3 receptor or a conditional deletion of the S1P1 receptor in
nociceptive primary afferents. Furthermore, neutralization of S1Pwith a selective anti-S1P
antibody did not abolish platelet induced heat hypersensitivity. Our results suggest that
activated platelets release S1P and induce heat hypersensitivity in vivo. However, the
platelet induced heat hypersensitivity was caused by mediators other than S1P.
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Introduction
Acute tissue injury, e.g., occurring as a consequence of local trauma or surgery, usually initiates local
platelet aggregation, blood coagulation, closure of blood vessels, and later the classical symptoms
of inflammation, that is redness, swelling, local warming, loss of function, and pain. Post-injury
pain results from an excitation and sensitization of nociceptor primary afferent nerve fibers by
inflammatory mediators accumulating at the site of inflammation. Such mediators are released by
activated immune cells, including mast cells, neutrophils and macrophages, but also by platelets,
which are attracted and activated by cell-attached or diffusible components of the traumatized
tissue (Basbaum et al., 2009).
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Platelets are among the first defense line to arrive at the site of
injury and in addition to their function in hemostasis they play
important roles during inflammatory processes (Semple et al.,
2011). Numerous mediators are released after platelet activa-
tion including adenosine 5′-diphosphate (ADP), adenosine 5′-
triphosphate (ATP), histamine, serotonin (5-hydroxytryptamine,
5-HT), thromboxane A2 (TXA2), platelet activating factor (PAF),
interleukin-1β (IL-1β) and many of these compounds activate
nociceptors and induce pain and hyperalgesia (for review see
Petho and Reeh, 2012). Increasing evidence is available for the
rapid release of sphingosine 1-phosphate (S1P) (Yatomi et al.,
2000), an ubiquitously expressed bioactive lipid mediator, which
is generated intracellularly from sphingosine via phosphoryla-
tion by sphingosine kinases 1 or 2 (Spiegel and Milstien, 2003).
S1P is abundantly stored in platelets, as these cells do not express
enzymes for S1P degradation (Spiegel and Milstien, 2011). Upon
activation platelets release S1P (Yatomi et al., 1995; Ulrych et al.,
2011), which may then bind to one of its cognate G protein-
coupled receptors (S1P1−5) located in the plasma membrane of
its target cells (Spiegel and Milstien, 2011). In recent studies S1P
has been demonstrated to induce nociceptor sensitization and
excitation and these effects are transduced by S1P1 and S1P3
receptors, respectively (Zhang et al., 2006; Chi and Nicol, 2010;
Mair et al., 2011; Camprubí-Robles et al., 2013).
In the present study, we assessed a possible S1P mediated
pronociceptive action of activated human platelets in an in vivo
mouse model. For this purpose, we intracutaneously injected
activated human platelet preparations into the mouse hind paw
and monitored reflex withdrawal responses to standard heat
stimuli at different time points post-injection. Platelet injection
induced significant hypersensitivity to heat stimuli, which per-
sisted for several hours. Furthermore, we quantified the S1P
content of platelet preparations and investigated a possible corre-
lation of the platelet concentration with the degree of hypersensi-
tivity. Finally, we assessed whether the observed increase in heat
sensitivity was based on a direct activation of nociceptors via S1P1
or S1P3 receptors in two different transgenicmouse strains, either
lacking S1P1 in Nav1.8 expressing nociceptive neurons (SNS-
S1P
−/−
1 ) or with a global null mutation for S1P3, and whether
neutralization of S1P in the platelet preparations, as published
previously in a different model (Finley et al., 2013), prevented the
development of heat hypersensitivity upon platelet injection.
Materials and Methods
Ethics Statement
All animal experiments were performed in accordance with
national Austrian law and ethical guidelines of the IASP (Inter-
national Association for the Study of Pain) (Zimmermann,
1986), and with permission of the Austrian Bundesministerium
für Wissenschaft und Forschung (BMWF) (BMWF-
66.011/0051-II/10b2008; BMWF-66.011/0113-II/3b/2010;
GZ 66.011/85-C/GT/2007).
Genetically Modified Mice
All experiments were performed in age-matched awake, unre-
strained, male C57BL/6J mice (8–12 weeks old), which were
housed on a 12 h light/dark cycle with free access to food and
water. Wt, S1P
fl/fl
1 , SNS-S1P
−/−
1 and S1P
−/−
3 mice were used
for the experiments.
Mice homozygous for the lox P flanked exon 2 allele of
the S1P1 receptor gene (S1P
fl/fl
1 ) and global S1P3 receptor null
mutant mice (S1P
−/−
3 ) have been described previously (Ishii,
2001; Allende et al., 2003; Kono et al., 2004). Since mice with
a global null mutation of S1P1 are not viable, S1P
fl/fl
1 mice
were cross-bred with SNS-Cre mice (Agarwal et al., 2004) to
obtain SNS-Cre:S1P
fl/fl
1 mice (subsequently referred to as SNS-
S1P
−/−
1 ) which selectively lack the S1P1 receptor in Nav1.8
channel-expressing nociceptive neurons (Mair et al., 2011).
Platelet Preparation
Human platelet concentrates were a generous gift of the Blood
Bank of the University Medical Center, Innsbruck. Individual
bags held at least 2 × 1011 platelets per bag. The content was
centrifuged (20min at 10.6 g and 10◦C) and the supernatant
was removed. Subsequently, platelets were resuspended in 20ml
PBS (Dulbecco’s PBS w/o Ca2+ and Mg2+; PAA, Pasching, Aus-
tria). Aliquots of different concentrations (105, 106 and 107
platelets/µl) were prepared and frozen at −80◦C. Prior to injec-
tion aliquots were defrosted and through this procedure platelets
were activated (Rauch et al., 2011). In addition thawed platelets
were sonicated (20min) and centrifuged (20min at 10.6 g and
10◦C) to obtain supernatant which was immediately used for
further experiments. The murine monoclonal anti-S1P anti-
body, Sphingomab/LT1002 and its inactive isotype mAb con-
trol, LT1017, (Lpath Incorporated, San Diego, CA, USA, O’Brien
et al., 2009) were added to the activated platelet preparations (107
platelets/µl) immediately prior to injection with a final concen-
tration of 0.03µg antibody per 1µl of platelet preparation as
published previously (Finley et al., 2013).
Heat Sensitivity
Heat sensitivity was assessed by using the Hargreaves test (Harg-
reaves et al., 1988). A radiant heat source delivering an increasing
heat stimulus was focused under the plantar surface of the hind-
paw. The time until the mouse responded to stimulation with
reflex paw withdrawal (paw withdrawal latency [PWL] in sec-
onds) was measured automatically with an algesiometer (Ugo
Basile, Comerio, Italy). Each hindpaw was tested at least three
times and the mean withdrawal latency was calculated. The time
interval between two trials on the same hindpaw was at least
1min. Baseline measurements were taken the day before and on
the day of injection. Platelets, platelets + LT1002, platelets +
LT1017 or PBS were injected intracutaneously in a total volume
of 10µl using a Hamilton syringe. Changes in heat sensitivity
were assessed 30min, 1, 2, 3, and 24 h post-injection. Experi-
menters were blinded either to the genotype of the mice or to
the injected substance.
S1P Concentration Analysis
Sphingolipids were liquid-liquid extracted from a 50µL sam-
ple using methanol:chloroform:HCl (15:83:2, v/v/v). After
evaporation of the organic layer and reconstitution in methanol,
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sample analysis was performed by using liquid chromatography–
electrospray ionization-tandem mass spectrometry (LC–ESI-
MS/MS). For HPLC an Agilent 1100 Series binary pump and
degasser connected to an HTC PAL autosampler (Chromtech,
Idstein, Germany) was used. A triple quadrupole mass spec-
trometer 4000 Q TRAP equipped with a Turbo V source ion
spray operating in positive ESI mode was used for detection
(AB Sciex, Darmstadt, Germany). High purity nitrogen for the
mass spectrometer was produced by the nitrogen generator NGM
22-LC/MS (cmc Instruments, Eschborn, Germany).
Chromatographic separations were obtained under gradient
conditions using a Luna C18 column (150 × 2mm i.d., 5µm
particle size) with a same material guard column (4mmL ×
2mm i.d.) (Phenomenex, Aschaffenburg, Germany) and eluent
A (water/formic acid (100:0.1 v/v)) and eluent B [acetoni-
trile/tetrahydrofuran/formic acid (50:50:0.1 v/v)]. The flow rate
was set at 0.3ml/min and the runtime at 14min.
The mass spectrometer was operated in the positive ion-
ization mode with an electrospray voltage of 5400V at 400◦C.
Precursor-to-product ion transitions of m/z 380.1→264.2 for
S1P (collision energy 23V), m/z 300.3→252.3 for SPH (26V),
m/z 302.2→60.1 for SAPH (43V), m/z 382.1→284.1 for SA1P
(20V), m/z 366.2→250.1 for C17-S1P (internal standard, 23V)
and m/z 286.2→238.1 for C17-SPH (internal standard, 26V)
were used as quantifier for the multiple reaction monitoring
(MRM) with a dwell time of 100ms. All quadrupoles were work-
ing at unit resolution. Quantification was performed with Ana-
lyst Software V1.4 (AB Sciex, Darmstadt, Germany) using the
standard-addition method.
Statistical Analysis
For detailed statistical analysis the SigmaStat3 software pack-
age was used. Data are presented as mean ± s.e.m. Two-way
repeated measures ANOVA followed by Tukey post-hoc test or
Bonferroni post-hoc test and Mann-Whitney U-test for compar-
isons between groups were used. Differences were considered
statistically significant at p < 0.05.
Results
Platelet Induced Sensitivity to Heat Stimuli and
S1P Content of Platelet Preparations
In order to assess the effect of activated platelets on heat sen-
sitivity in vivo, platelet preparations of different concentra-
tions (105/µl, 106/µl, 107/µl) were injected into the hindpaw
of C57BL/6J mice. Upon injection, mice displayed little to no
nocifensive behavior (data not shown). Sensitivity to heat stim-
uli before and after platelet injection was measured as PWL and a
dose-dependent heat hypersensitivity after platelet injection was
observed (Figure 1A). Already 30min after injection of 107/µl
PWL significantly dropped from 13.62 ± 0.66 s at baseline to
3.31 ± 0.22 s (p < 0.001; Mann-Whitney U-test). Injection of
105/µl induced a maximal reduction in PWL of 18.78 ± 5.88%,
106/µl led to a maximal reduction in PWL of 31.01 ± 6.76%
and 107/µl resulted in a maximal reduction of 75.26 ± 2.24%.
Quantification of PWL 1 h after injection showed significant
differences between the different concentrations with a posi-
tive linear correlation (r2 = 0.9845, Figure 1C). The strongest
effect was seen after injection of platelets with a concentration of
107/µl. Over the course of several hours after the injection, PWL
recovered slowly and reached baseline values after 24 h.
Since platelets release their content after activation and it
was anticipated that one or more of the factors released were
responsible for the proalgesic action, we assessed whether the
supernatant of platelets activated by sonication likewise affected
heat sensitivity in vivo. Similar to activated platelets, the injec-
tion of the supernatant induced a significant reduction in PWL
from 13.13 ± 0.55 s at baseline to 6.24 ± 0.19 s within 30min
after injection (p < 0.05; Mann-Whitney U-test, Figure 1B).
The time course of heat hypersensitivity in response to injec-
tion of the supernatant was similar to the platelet prepara-
tions and the degree of hypersensitivity was greater than the
change observed with 106/µl but less severe than for the highest
concentration (107).
Like the majority of cells and tissues, circulating platelets gen-
erate S1P as the final product of the tightly regulated ceramide to
S1P pathway (Maceyka et al., 2002). Compelling evidence impli-
cates this pathway as a contributor to pain of diverse etiologies
(Mair et al., 2011; Camprubí-Robles et al., 2013; Salvemini et al.,
2013). Circulating platelets are a major source of extracellular
S1P and concentrations of 0.2–0.9µM (75–340 ng/ml) and 0.4–
1.1µM (150–415 ng/ml) have been reported for blood plasma
and serum, respectively, although S1P is largely bound to albu-
min and high-density lipoproteins (HDL) in these compartments
(Caligan et al., 2000; Murata et al., 2000; Berdyshev et al., 2005;
Spiegel andMilstien, 2011). We therefore quantified the S1P con-
tent of different platelet preparations with LC-MS/MS. As shown
in Figure 1D, S1P content significantly correlated with platelet
numbers (r2 = 0.999; 105/µl: 1.85± 0.65 ng/ml, 106/µl: 14.54±
2.73 ng/ml, 107/µl: 130.15± 35.38 ng/ml). In addition, the super-
natant of sonicated platelets contained 23.11 ± 2.57 ng/ml S1P,
suggesting that S1P was released from platelets upon activation
in physiologically relevant concentrations.
Role of S1P Receptors 1 and 3 in Mediating Heat
Hypersensitivity after Injection of Activated
Platelets
Of the five G protein coupled receptors of the S1P family known
to date (Chun et al., 2010), three have been located in primary
sensory neurons. While S1P1 is largely restricted to small diam-
eter neurons giving rise to nociceptors, S1P2 is present pre-
dominantly in large DRG neurons giving rise to low threshold
mechanosensors, which are insensitive to thermal stimuli. The
S1P3 receptor, in contrast, is expressed in virtually all sensory
neurons including peptidergic and non-peptidergic nociceptors
(Camprubí-Robles et al., 2013).
Therefore, we assessed platelet induced heat hypersensitivity
in SNS-S1P
−/−
1 mice, which lack the S1P1 receptor specifically in
Nav1.8 expressing primary nociceptive afferents. As shown in
Figure 2, injection of activated platelets (107/µl) led to simi-
lar reactions in both SNS-S1P
−/−
1 and S1P
fl/fl
1 control mice
(Two-Way Repeated Measures ANOVA: n.s.) suggesting that
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FIGURE 1 | Activated platelets increased thermal sensitivity in vivo.
(A) After intracutaneous injection of platelet preparations (10µl) in different
concentrations a dose-dependent reduction of paw withdrawal latency
(PWL) was observed. Heat sensitization recovered to baseline after 24 h. (B)
Injection of the supernatant of sonicated platelets led to a reduction in PWL
as well. (C) Quantification of PWL shown in (A,B) 1 h after injection
(*p < 0.05, **p < 0.01, ***p < 0.001; Mann Whitney U-test). (D) S1P
concentration in platelet preparations as measured with HPLC. S1P
concentration was directly proportional to platelet concentration (*p < 0.05,
**p < 0.01; Mann Whitney U-test).
S1P1 receptors expressed by nociceptors do not contribute to the
platelet induced heat hypersensitivity.
In addition to the S1P1 receptor, small sensory neurons
express the S1P3 receptor and it has been shown that these recep-
tors mediate ongoing pain behavior induced by S1P injections
in mice and humans (Camprubí-Robles et al., 2013). However,
activated platelets (107/µl) induced significant hypersensitivity
to heat stimulation in both S1P
−/−
3 and wild-type control mice,
and the degree of hypersensitivity was similar for S1P
−/−
3 and
wild-type control mice (Two-Way Repeated Measures ANOVA:
n.s.; Figure 3). This suggests that S1P released by activated
platelets does not directly affect nociceptors to induce nociceptor
sensitization and hypersensitivity to heat.
Role of S1P as Mediator of Platelet Induced Heat
Hypersensitivity
Since heat hypersensitivity was preserved in both transgenic
mouse models, a possible indirect mechanism of nociceptor sen-
sitization was anticipated for S1P released from platelets. In
order to test this hypothesis, platelet preparations were mixed
with either the murine monoclonal anti-S1P antibody, Sphin-
gomab/LT1002, or its isotype mAB control, LT1017, prior to
injection. Necessary antibody concentrations were calculated
based on the S1P content of platelet preparations measured
by LC-MS/MS. Platelet preparations containing the anti-S1P
antibody, Sphingomab/LT1002, as well as preparations con-
taining the control antibody, LT1017, or no antibody, led to
a significant decrease in PWL 30min after injection, when
compared to PBS control injections (Figure 4). Injection of
PBS induced a maximal reduction in PWL of 30.06 ± 7.06%,
platelets led to a maximal reduction in PWL of 70.35 ±
4.12%, platelets + LT1002 resulted in a maximal reduction in
PWL of 61.92 ± 6.00% and platelets + LT1017 brought about
a maximal reduction in PWL of 49.02 ± 6.04% (Two-Way
RepeatedMeasures ANOVAwith Bonferroni post-hoc test, ∗∗p <
0.01 vs. PBS). This suggests, that S1P released by activated
platelets did not play a major role in platelet-induced heat
hypersensitivity.
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FIGURE 2 | Thermal hypersensitivity after injection of activated
platelets not mediated through the S1P1 receptor. After intracutaneous
injection of platelet preparations (10µl; 107 platelets/µl) no differences in PWL
reduction were detected between SNS-S1P
−/−
1 and S1P
fl/fl control mice
(Two-Way Repeated Measures ANOVA: n.s.).
FIGURE 3 | Thermal hypersensitivity after injection of activated
platelets not mediated through the S1P3 receptor. After intracutaneous
injection of platelet preparations (10µl; 107 platelets/µl) no differences in PWL
reduction were obtained between S1P
−/−
3 and wild-type (WT) control mice
(Two-Way Repeated Measures ANOVA: n.s.).
Discussion
In this study we provide evidence that activated platelets had a
pronociceptive effect in vivo.We demonstrate that mice injected
with platelet preparations of increasing concentrations displayed
an augmented sensitivity to heat stimuli in a dose-dependent
manner, which was detectable for several hours after injection.
Despite the substantial amounts of S1P that were released by
platelets upon activation, the platelet induced heat sensitization
was independent not only of S1P1 and S1P3 receptors expressed
in nociceptors, but more importantly, S1P did obviously not
contribute to platelet induced nociceptor sensitization.
Earlier studies have demonstrated that platelets are capable of
driving a subset of primary afferent neurons that sense poten-
tially noxious events, the nociceptors. For example, activated
human platelets excite mechano-heat responsive C-nociceptors
FIGURE 4 | Thermal hypersensitivity after injection of activated
platelets not mediated through indirect mechanisms of S1P.
Intracutaneous injection of platelet preparations (10µl; 107 platelets/µl) with or
without a neutralizing anti-S1P antibody (LT1002) or an inactive antibody
(LT1017) led to a strong reduction in PWL, whereas injection of PBS resulted in
a minor reduction in PWL (Two-Way Repeated Measures ANOVA with
Bonferroni post-hoc test, **p < 0.01 vs. PBS).
in an in vitro skin-nerve preparation of rat hairy skin (Ringkamp
et al., 1994). Furthermore, intracutaneous injections of acti-
vated platelets resulted in acute pain and hyperalgesia in human
volunteers (Schmelz et al., 1997; Blunk et al., 1999).
Although platelets are known to play essential roles dur-
ing inflammatory processes and have been shown to contain a
plethora of pro-inflammatory and anti-inflammatory cytokines
and chemokines, proteases, ADP, ATP, histamine, 5-HT, TXA2,
PAF, IL-1β, and S1P (reviewed in Horstman et al., 2010; Semple
et al., 2011;Ware et al., 2013), the nature of the mediators that are
most relevant for nociception have yet to be elucidated. Several of
these pro-inflammatory mediators have been assessed in various
models of pathological pain conditions including inflammatory
pain (Basbaum et al., 2009). ATP has been extensively studied in
the context of nociceptor activation and sensitization (reviewed
in Bland-Ward and Humphrey, 2000; Burnstock, 2000; Wirkner
et al., 2007) and may also directly or indirectly modulate TRPV1
(Lishko et al., 2007).
Some mediators released from platelets have been shown to
act synergistically with other factors, such as bradykinin (BK)
(Koppert et al., 1993) and TXA2 (Hori et al., 1986). The BK recep-
tors may be upregulated upon tissue injury or after the release
of cytokines such as IL-1β (Marceau et al., 1998), which is also
stored in and released from platelets. Another classical algogen
which sensitizes nociceptors is 5-HT (Lang et al., 1990; Taiwo
and Levine, 1992; Babenko et al., 2000; Ernberg et al., 2000, 2006;
Schmelz et al., 2003). Finally, platelet activating factor (PAF)
induces spontaneous nociception and mechanical hypersensitiv-
ity in addition to its known functions during inflammation and
hemostasis (Teather et al., 2002; Marotta et al., 2009).
In addition to these mediators, circulating platelets together
with red blood cells are generally accepted as a major source of
extracellular S1P in blood (Yatomi, 2008). In the present study,
platelet preparations contained substantial amounts of this bioac-
tive sphingolipid and S1P was released into the supernatant after
Frontiers in Neuroscience | www.frontiersin.org 5 April 2015 | Volume 9 | Article 140
Weth et al. S1P, platelets, and pain
activation. So far the S1P release mechanism from platelets has
not fully been elucidated, but platelets contain two releasable
pools of S1P: a non-granular one for the constitutive release with-
out stimulation and a granular one that is released upon activa-
tion and requires regulated exocytosis (Jonnalagadda et al., 2014).
In addition, platelets are known to express the ATP-binding cas-
sette transporter 4 (ABCC4) protein (Jedlitschky et al., 2004) and
the release of S1P from human platelets can be blocked with
the ABCC transporter-inhibitor MK751 (Ulrych et al., 2011). In
line with these reports, S1P was detectable in physiologically rel-
evant concentrations after platelet activation by freeze/thawing
in vitro, which has been established to be a very effective method
of activation (Rauch et al., 2011).
However, it remains elusive whether similar concentrations of
S1P at the nociceptors are reached upon platelet injection into
the mouse hind paw, but it can be anticipated that 80% of the S1P
contained within the platelets is released within 5min after acti-
vation as it has been shown in in vitro studies (Kobayashi et al.,
2006; Jonnalagadda et al., 2014)We hypothesized that the prono-
ciceptive effect of activated platelets in vivo was based on S1P
release and downstream activation of S1P receptors located in the
plasma membrane of nociceptive neurons. This paracrine signal-
ing of S1P is important in inflammatory processes where free S1P
levels increase substantially at the site of inflammation (Spiegel
and Milstien, 2003; Takabe et al., 2008).
In dorsal root ganglia (DRG), where the cell bodies of noci-
ceptive neurons are located, all five S1P receptors are expressed
(Kays et al., 2012), but small diameter nociceptive neuronsmainly
express S1P1 and S1P3 (Mair et al., 2011; Camprubí-Robles et al.,
2013). Several lines of evidence support the idea that increased
heat hypersensitivity after S1P injection is mediated by the S1P1
receptor located on primary nociceptive afferents (Doyle et al.,
2011; Mair et al., 2011; Xie et al., 2012). After injection of S1P
into the hindpaw the resulting heat hypersensitivity is signifi-
cantly reduced in SNS-S1P
−/−
1 mice as compared to S1P
fl/fl
1
control mice. At the same time, S1P3 activation induces nocicep-
tor excitation with action potential firing in a cellular pain model
and spontaneous pain behavior in vivo and S1P
−/−
3 display a
significantly reduced spontaneous pain behavior and recover sig-
nificantly faster from post-surgical pain (Camprubí-Robles et al.,
2013).
Surprisingly, the heat hypersensitivity occurring after platelet
injection was fully preserved in both knock-out mouse strains in
the current study. Despite converging evidence for a proalgesic
and receptor-mediated action of S1P, S1P receptors expressed in
nociceptive neurons were not critically involved in the pronoci-
ceptive action of platelets reported here. This could have been
explained by spatio-temporal confinement, which has become
a generally accepted mechanism for the regulation of complex
biochemical networks (Shen et al., 2009). In particular tight bind-
ing of S1P to the components of serum or plasma, including
lipoproteins, may interfere with S1P binding to its receptors
and thereby attenuate the lipid-receptor-mediated actions in the
cells (Murata et al., 2000). The strong association of platelets
with apolipoproteins and other components of HDL, which also
behave as carriers for S1P, together with the HDL complex seems
to have effects that are completely different from those observed
for free S1P and this is currently extensively studied in the cardio-
vascular system (Scanu and Edelstein, 2008; Kennedy et al., 2009).
However, the lack of effect of S1P neutralization rather suggests
that S1P released from activated platelets does not play a role in
nociceptor sensitization.
Conclusions
In the present study we provide evidence that activated platelets
have a pronociceptive effect and thus may be implicated in post-
operative pain. Although platelets contain and release substan-
tial levels of S1P, an action of S1P, either directly via neuronally
expressed receptors S1P1 and S1P3 or via indirect mechanisms,
for the establishment of the observed heat hypersensitivity of
nociceptors was not supported in the current settings. Although
S1P and its receptors S1P1 and S1P3 are critically important reg-
ulators of nociception for which pronociceptive effects via direct
regulation of nociceptors have been reported previously (Mair
et al., 2011; Camprubí-Robles et al., 2013) the pronociceptive
effect of activated platelets involves mediators other than S1P to
modulate nociceptor heat sensitivity.
Author Contributions
Conceived and designed the experiments: DW, CB, GGs, GGe,
RS, MK. Performed the experiments: DW, CB, HS. Ana-
lyzed the experiments: DW, CB, HS, GGe, MK. Contributed
reagents/materials/analytic tools: CR, RP, GGs, GGe, RS, MK.
Wrote the manuscript: DW, RP, GGs, GGe, MK. All authors read
and approved the final manuscript.
Acknowledgments
This work was supported by the Austrian Research Funding
Agency FWF (project grants P20562, P25345, and SPIN-01206-
B6) toMK, SFB 1039/Z01 to GGe and by the Intramural Research
Programs of the National Institutes of Health, National Institute
of Diabetes andDigestive andKidneyDiseases to RP. The authors
thank Kathrin Braun, TheresaMartha andMarkus Doblander for
expert technical assistance.
References
Agarwal, N., Offermanns, S., and Kuner, R. (2004). Conditional gene deletion in
primary nociceptive neurons of trigeminal ganglia and dorsal root ganglia.
Genesis 38, 122–129. doi: 10.1002/gene.20010
Allende, M. L., Yamashita, T., and Proia, R. L. (2003). G-protein-coupled receptor
S1P1 acts within endothelial cells to regulate vascular maturation. Blood 102,
3665–3667. doi: 10.1182/blood-2003-02-0460
Babenko, V., Svensson, P., Graven-Nielsen, T., Drewes, A. M., Jensen, T. S.,
and Arendt-Nielsen, L. (2000). Duration and distribution of experimental
Frontiers in Neuroscience | www.frontiersin.org 6 April 2015 | Volume 9 | Article 140
Weth et al. S1P, platelets, and pain
muscle hyperalgesia in humans following combined infusions of serotonin and
bradykinin. Brain Res. 853, 275–281. doi: 10.1016/S0006-8993(99)02270-2
Basbaum, A. I., Bautista, D. M., Scherrer, G., and Julius, D. (2009).
Cellular and molecular mechanisms of pain. Cell 139, 267–284. doi:
10.1016/j.cell.2009.09.028
Berdyshev, E. V., Gorshkova, I. A., Garcia, J. G. N., Natarajan, V., and Hubbard,
W. C. (2005). Quantitative analysis of sphingoid base-1-phosphates as bisacety-
lated derivatives by liquid chromatography-tandem mass spectrometry. Anal.
Biochem. 339, 129–136. doi: 10.1016/j.ab.2004.12.006
Bland-Ward, P. A., and Humphrey, P. P. A. (2000). P2X receptors mediate ATP-
induced primary nociceptive neurone activation. J. Auton. Nerv. Syst. 81,
146–151. doi: 10.1016/S0165-1838(00)00122-3
Blunk, J., Osiander, G., Nischik, M., and Schmelz, M. (1999). Pain and inflam-
matory hyperalgesia induced by intradermal injections of human platelets and
leukocytes. Eur. J. Pain 3, 247–259. doi: 10.1016/S1090-3801(99)90052-6
Burnstock, G. (2000). P2X receptors in sensory neurones. Br. J. Anaesth. 84,
476–488. doi: 10.1093/oxfordjournals.bja.a013473
Caligan, T. B., Peters, K., Ou, J., Wang, E., Saba, J., and Merrill, A. H. (2000). A
high-performance liquid chromatographic method to measure sphingosine 1-
phosphate and related compounds from sphingosine kinase assays and other
biological samples. Anal. Biochem. 281, 36–44. doi: 10.1006/abio.2000.4555
Camprubí-Robles, M., Mair, N., Andratsch, M., Benetti, C., Beroukas, D., Ruk-
wied, R., et al. (2013). Sphingosine-1-phosphate-induced nociceptor excitation
and ongoing pain behavior in mice and humans is largely mediated by S1P3
receptor. J. Neurosci. 33, 2582–2592. doi: 10.1523/JNEUROSCI.4479-12.2013
Chi, X. X., and Nicol, G. D. (2010). The sphingosine 1-phosphate receptor, S1PR1,
plays a prominent but not exclusive role in enhancing the excitability of sensory
neurons. J. Neurophysiol. 104, 2741–2748. doi: 10.1152/jn.00709.2010
Chun, J., Hla, T., Lynch, K. R., Spiegel, S., and Moolenaar, W. H. (2010).
International Union of Basic and clinical pharmacology. LXXVIII.
Lysophospholipid receptor nomenclature. Pharmacol. Rev. 62, 579–587.
doi: 10.1124/pr.110.003111
Doyle, T., Finley, A., Chen, Z., and Salvemini, D. (2011). Role for peroxynitrite in
sphingosine-1-phosphate-induced hyperalgesia in rats. Pain 152, 643–648. doi:
10.1016/j.pain.2010.12.011
Ernberg, M., Hedenberg-Magnusson, B., Kurita, H., and Kopp, S. (2006). Effects
of local serotonin administration on pain and microcirculation in the human
masseter muscle. J. Orofac. Pain 20, 241–248.
Ernberg, M., Lundeberg, T., and Kopp, S. (2000). Pain and allodynia/hyperalgesia
induced by intramuscular injection of serotonin in patients with fibromyalgia
and healthy individuals. Pain 85, 31–39. doi: 10.1016/S0304-3959(99)00233-X
Finley, A., Chen, Z., Esposito, E., Cuzzocrea, S., Sabbadini, R., and Salvem-
ini, D. (2013). Sphingosine 1-phosphate mediates hyperalgesia via a
neutrophil-dependent mechanism. PLoS ONE 8:e55255. doi: 10.1371/jour-
nal.pone.0055255
Hargreaves, K., Dubner, R., Brown, F., Flores, C., and Joris, J. (1988). A new and
sensitive method for measuring thermal nociception in cutaneous hyperalgesia.
Pain 32, 77–88. doi: 10.1016/0304-3959(88)90026-7
Hori, Y., Katori, M., Harada, Y., Uchida, Y., and Tanaka, K. (1986). Potentiation of
bradykinin-induced nociceptive response by arachidonate metabolites in dogs.
Eur. J. Pharmacol. 132, 47–52. doi: 10.1016/0014-2999(86)90007-5
Horstman, L. L., Jy, W., Ahn, Y. S., Zivadinov, R., Maghzi, A. H., Etemadifar, M.,
et al. (2010). Role of platelets in neuroinflammation: a wide-angle perspective.
J. Neuroinflammation 7:10. doi: 10.1186/1742-2094-7-10
Ishii, I. (2001). Selective loss of sphingosine 1-phosphate signaling with no obvi-
ous phenotypic abnormality in mice lacking its G protein-coupled receptor,
LPB3/EDG-3. J. Biol. Chem. 276, 33697–33704. doi: 10.1074/jbc.M104441200
Jedlitschky, G., Tirschmann, K., Lubenow, L. E., Nieuwenhuis, H. K., Akkerman, J.
W. N., Greinacher, A., et al. (2004). The nucleotide transporter MRP4 (ABCC4)
is highly expressed in human platelets and present in dense granules, indicating
a role in mediator storage. Blood 104, 3603–3610. doi: 10.1182/blood-2003-12-
4330
Jonnalagadda, D., Sunkara, M., Morris, A. J., and Whiteheart, S. W. (2014).
Granule-mediated release of sphingosine-1-phosphate by activated platelets.
Biochim. Biophys. Acta 1841, 1581–1589. doi: 10.1016/j.bbalip.2014.08.013
Kays, J. S., Li, C., and Nicol, G. D. (2012). Expression of sphingosine 1-phosphate
receptors in the rat dorsal root ganglia and defined single isolated sensory neu-
rons. Physiol. Genomics 44, 889–901. doi: 10.1152/physiolgenomics.00053.2012
Kennedy, S., Kane, K. A., Pyne, N. J., and Pyne, S. (2009). Targeting sphingosine-1-
phosphate signalling for cardioprotection. Curr. Opin. Pharmacol. 9, 194–201.
doi: 10.1016/j.coph.2008.11.002
Kobayashi, N., Nishi, T., Hirata, T., Kihara, A., Sano, T., Igarashi, Y., et al. (2006).
Sphingosine 1-phosphate is released from the cytosol of rat platelets in a
carrier-mediated manner. J. Lipid Res. 47, 614–621. doi: 10.1194/jlr.M500468-
JLR200
Kono, M., Mi, Y., Liu, Y., Sasaki, T., Allende, M. L., Wu, Y.-P., et al. (2004).
The Sphingosine-1-phosphate receptors S1P1, S1P2, and S1P3 function coor-
dinately during embryonic angiogenesis. J. Biol. Chem. 279, 29367–29373. doi:
10.1074/jbc.M403937200
Koppert, W., Reeh, P. W., and Handwerker, H. O. (1993). Conditioning of his-
tamine by bradykinin alters responses of rat nociceptor and human itch
sensation. Neurosci. Lett. 152, 117–120. doi: 10.1016/0304-3940(93)90497-9
Lang, E., Novak, A., Reeh, P. W., and Handwerker, H. O. (1990). Chemosensitivity
of fine afferents from rat skin in vitro. J. Neurophysiol. 63, 887–901.
Lishko, P. V., Procko, E., Jin, X., Phelps, C. B., and Gaudet, R. (2007). The ankyrin
repeats of TRPV1 bind multiple ligands and modulate channel sensitivity.
Neuron 54, 905–918. doi: 10.1016/j.neuron.2007.05.027
Maceyka, M., Payne, S. G., Milstien, S., and Spiegel, S. (2002). Sphingosine
kinase, sphingosine-1-phosphate, and apoptosis. Biochim. Biophys. Acta 1585,
193–201. doi: 10.1016/S1388-1981(02)00341-4
Mair, N., Benetti, C., Andratsch, M., Leitner, M. G., Constantin, C. E., Camprubí-
Robles, M., et al. (2011). Genetic evidence for involvement of neuronally
expressed S1P1 receptor in nociceptor sensitization and inflammatory pain.
PLoS ONE 6:e17268. doi: 10.1371/journal.pone.0017268
Marceau, F., Hess, J. F., and Bachvarov, D. R. (1998). The B1 receptors for kinins.
Pharmacol. Rev. 50, 357–386.
Marotta, D. M., Costa, R., Motta, E. M., Fernandes, E. S., Medeiros, R., Quin-
tão, N. L. M., et al. (2009). Mechanisms underlying the nociceptive responses
induced by platelet-activating factor (PAF) in the rat paw. Biochem. Pharmacol.
77, 1223–1235. doi: 10.1016/j.bcp.2008.12.025
Murata, N., Sato, K., Kon, J., Tomura, H., Yanagita, M., Kuwabara, A., et al. (2000).
Interaction of sphingosine 1-phosphate with plasma components, including
lipoproteins, regulates the lipid receptor-mediated actions. Biochem. J. 352(Pt
3), 809–815. doi: 10.1042/0264-6021:3520809
O’Brien, N., Jones, S. T., Williams, D. G., Cunningham, H. B., Moreno, K.,
Visentin, B., et al. (2009). Production and characterization of monoclonal
anti-sphingosine-1-phosphate antibodies. J. Lipid Res. 50, 2245–2257. doi:
10.1194/jlr.M900048-JLR200
Petho, G., and Reeh, P. W. (2012). Sensory and signaling mechanisms of
bradykinin, eicosanoids, platelet-activating factor, and nitric oxide in peripheral
nociceptors. Physiol. Rev. 92, 1699–1775. doi: 10.1152/physrev.00048.2010
Rauch, C., Feifel, E., Amann, E.-M., Spötl, H. P., Schennach, H., Pfaller, W.,
et al. (2011). Alternatives to the use of fetal bovine serum: human platelet
lysates as a serum substitute in cell culture media. ALTEX 28, 305–316. doi:
10.14573/altex.2011.4.305
Ringkamp, M., Schmelz, M., Kress, M., Allwang, M., Ogilvie, A., and Reeh, P.
W. (1994). Activated human platelets in plasma excite nociceptors in rat skin,
in vitro. Neurosci. Lett. 170, 103–106. doi: 10.1016/0304-3940(94)90249-6
Salvemini, D., Doyle, T., Kress, M., and Nicol, G. (2013). Therapeutic targeting of
the ceramide- to-sphingosine 1-phosphate pathway in pain. Trends Pharmacol.
Sci. 34, 110–118. doi: 10.1016/j.tips.2012.12.001
Scanu, A. M., and Edelstein, C. (2008). HDL: bridging past and present with a look
at the future. FASEB J. 22, 4044–4054. doi: 10.1096/fj.08-117150
Schmelz, M., Osiander, G., Blunk, J., Ringkamp, M., Reeh, P. W., and Handw-
erker, H. O. (1997). Intracutaneous injections of platelets cause acute pain
and protracted hyperalgesia. Neurosci. Lett. 226, 171–174. doi: 10.1016/S0304-
3940(97)00269-3
Schmelz, M., Schmidt, R., Weidner, C., Hilliges, M., Torebjork, H. E., and Handw-
erker, H. O. (2003). Chemical response pattern of different classes of C-
nociceptors to pruritogens and algogens. J. Neurophysiol. 89, 2441–2448. doi:
10.1152/jn.01139.2002
Semple, J. W., Italiano, J. E., and Freedman, J. (2011). Platelets and the immune
continuum. Nat. Rev. Immunol. 11, 264–274. doi: 10.1038/nri2956
Shen, F., Pompano, R. R., Kastrup, C. J., and Ismagilov, R. F. (2009). Confine-
ment regulates complex biochemical networks: initiation of blood clotting by
“diffusion acting”. Biophys. J. 97, 2137–2145. doi: 10.1016/j.bpj.2009.08.004
Frontiers in Neuroscience | www.frontiersin.org 7 April 2015 | Volume 9 | Article 140
Weth et al. S1P, platelets, and pain
Spiegel, S., and Milstien, S. (2003). Sphingosine-1-phosphate: an enigmatic sig-
nalling lipid. Nat. Rev. Mol. Cell Biol. 4, 397–407. doi: 10.1038/nrm1103
Spiegel, S., and Milstien, S. (2011). The outs and the ins of sphingosine-1-
phosphate in immunity. Nat. Rev. Immunol. 11, 403–415. doi: 10.1038/nri2974
Taiwo, Y. O., and Levine, J. D. (1992). Serotonin is a directly-acting hyperal-
gesic agent in the rat. Neuroscience 48, 485–490. doi: 10.1016/0306-4522(92)
90508-Y
Takabe, K., Paugh, S. W., Milstien, S., and Spiegel, S. (2008). “Inside-out” signaling
of sphingosine-1-phosphate: therapeutic targets. Pharmacol. Rev. 60, 181–195.
doi: 10.1124/pr.107.07113
Teather, L. A., Magnusson, J. E., and Wurtman, R. J. (2002). Platelet-activating
factor antagonists decrease the inflammatory nociceptive response in rats.
Psychopharmacology 163, 430–433. doi: 10.1007/s00213-002-1039-9
Ulrych, T., Böhm, A., Polzin, A., Daum, G., Nüsing, R. M., Geisslinger, G.,
et al. (2011). Release of sphingosine-1-phosphate from human platelets is
dependent on thromboxane formation. J. Thromb. Haemost. 9, 790–798. doi:
10.1111/j.1538-7836.2011.04194.x
Ware, J., Corken, A., and Khetpal, R. (2013). Platelet function beyond
hemostasis and thrombosis. Curr. Opin. Hematol. 20, 451–456. doi:
10.1097/MOH.0b013e32836344d3
Wirkner, K., Sperlagh, B., and Illes, P. (2007). P2X3 receptor involvement in pain
states.Mol. Neurobiol. 36, 165–183. doi: 10.1007/s12035-007-0033-y
Xie, W., Strong, J. A., Kays, J., Nicol, G. D., and Zhang, J.-M. (2012). Knockdown
of the sphingosine-1-phosphate receptor S1PR1reduces pain behaviors induced
by local inflammation of the rat sensory ganglion. Neurosci. Lett. 515, 61–65.
doi: 10.1016/j.neulet.2012.03.019
Yatomi, Y. (2008). Plasma sphingosine 1-phosphate metabolism and analysis.
Biochim. Biophys. Acta 1780, 606–611. doi: 10.1016/j.bbagen.2007.10.006
Yatomi, Y., Ohmori, T., Rile, G., Kazama, F., Okamoto, H., Sano, T., et al. (2000).
Sphingosine 1-phosphate as a major bioactive lysophospholipid that is released
from platelets and interacts with endothelial cells. Blood 96, 3431–3438.
Yatomi, Y., Ruan, F., Hakomori, S., and Igarashi, Y. (1995). Sphingosine-1-
phosphate: a platelet-activating sphingolipid released from agonist-stimulated
human platelets. Blood 86, 193–202.
Zhang, Y. H., Fehrenbacher, J. C., Vasko, M. R., and Nicol, G. D. (2006).
Sphingosine-1-phosphate via activation of a G-protein-coupled receptor(s)
enhances the excitability of rat sensory neurons. J. Neurophysiol. 96, 1042–1052.
doi: 10.1152/jn.00120.2006
Zimmermann, M. (1986). Ethical considerations in relation to pain in animal
experimentation. Acta Physiol. Scand. 128, 221–233.
Conflict of Interest Statement: The authors declare that the research was con-
ducted in the absence of any commercial or financial relationships that could be
construed as a potential conflict of interest.
Copyright © 2015 Weth, Benetti, Rauch, Gstraunthaler, Schmidt, Geisslinger,
Sabbadini, Proia and Kress. This is an open-access article distributed under the
terms of the Creative Commons Attribution License (CC BY). The use, distribution or
reproduction in other forums is permitted, provided the original author(s) or licensor
are credited and that the original publication in this journal is cited, in accordance
with accepted academic practice. No use, distribution or reproduction is permitted
which does not comply with these terms.
Frontiers in Neuroscience | www.frontiersin.org 8 April 2015 | Volume 9 | Article 140
